FDA Lets Some Changes To Monitoring Tools Bypass Clearance Process During COVID-19 Pandemic

Manufacturers can expand the remote-use capabilities of patient-monitoring devices like thermometers and stethoscopes without alerting the US FDA during the coronavirus crisis, a new guidance document from the agency says.

Remote medicine concept. Telemedicine.
• Source: Shutterstock

More from Regulation

More from Policy & Regulation